2012

• Islam, M., Reid, S., White, A., Grummett, S., Conigrave, K., Haber, P. (2012), Opportunistic and continuing health care for injecting drug users from a nurse-run needle syringe program-based primary health-care clinic. Drug and alcohol review. , 114-5; author reply 116-7. [Abstract]

2011

• Lipworth, W., Wodak, A., Haber, P., Day, R. (2011), Why is disulfiram not on the PBS?. The Medical journal of Australia. 195(7), 371-2. [Abstract]
• Demirkol, A., Haber, P., Conigrave, K. (2011), Problem drinking - detection and assessment in general practice. Australian Family Physician. 40(8), 570-574. [Abstract]
• Demirkol, A., Conigrave, K., Haber, P. (2011), Problem drinking - management in general practice. Australian Family Physician. 40(8), 576-582. [Abstract]
• Grebely, J., Matthews, G., Hellard, M., Shaw, D., van Beek, I., Petoumenos, K., Alavi, M., Yeung, B., Haber, P., Lloyd, A., Kaldor, J., Dore, G. (2011), Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users. Journal of hepatology. 55(1), 76-85. [Abstract]
• Seth, D., Haber, P., Syn, W., Diehl, A., Day, C. (2011), Pathogenesis of Alcohol-induced Liver Disease - classical concepts and recent advances. Journal of gastroenterology and hepatology. 26(7), 1089-105. [Abstract]
• Islam, M., Grummett, S., White, A., Reid, S., Day, C., Haber, P. (2011), A primary healthcare clinic in a needle syringe program may contribute to HIV prevention by early detection of incident HIV in an injecting drug user. Australian and New Zealand Journal of Public Health. , 294-295. [Abstract]
• Haber, P. (2011), International perspectives in postgraduate medical training in addiction medicine. Substance Abuse. 32, 75-76. [Abstract]
• Haber, P., Murnion, B. (2011), Training in addiction medicine in australia. Substance Abuse. 32(2), 115-119. [Abstract]
• Haber, P. (2011), Gastrointestinal disorders related to alcohol and other drug use. In: Principles of Addiction Medicine: The Essentials. (pp.0).United States: Lippincott Williams & Wilkins.
• Haber, P., Batey, R. (2011), Liver disorders related to alcohol and other drug use. In: Principles of Addiction Medicine: The Essentials. (pp.0).United States: Lippincott Williams & Wilkins.
• Burns, L., Conroy, E., Moore, E., Hutchinson, D., Haber, P. (2011), Psychosocial characteristics and obstetric health of women attending a specialist substance use antenatal clinic in a large metropolitan hospital. International Journal of Pediatrics. 2011, 729237. [Abstract]
• Day, C., Islam, M., White, A., Reid, S., Hayes, S., Haber, P. (2011), Development of a nurse-led primary healthcare service for injecting drug users in inner-city Sydney. Australian Journal of Primary Health. 17(1), 10-15. [Abstract]

2010

• Teesson, M., Hall, W., Slade, T., Mills, K., Grove, R., Mewton, L., Baillie, A., Haber, P. (2010), Prevalence and correlates of DSM-IV alcohol abuse and dependence in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing. Addiction (Abingdon, England). 105, 2085-94. [Abstract]
• Sanson-Fisher, R., Brand, M., Shakeshaft, A., Haber, P., Day, C., Conigrave, K., Mattick, R., Lintzeris, N., Teesson, M. (2010), Forming a national multicentre collaboration to conduct clinical trials: increasing high-quality research in the drug and alcohol field. Drug and Alcohol Review. 29(5), 469-474. [Abstract]
• Baillie, A., Stapinski, L., Crome, E., Morley, K., Sannibale, C., Haber, P., Teesson, M. (2010), Some new directions for research on psychological interventions for comorbid anxiety and substance use disorders. Drug and Alcohol Review. 29(5), 518-524. [Abstract]
• Boonwaat, L., Haber, P., Levy, M., Lloyd, A. (2010), Establishment of a successful assessment and treatment service for Australian prison inmates with chronic hepatitis C. The Medical Journal of Australia. 192(9), 496-500. [Abstract]
• Seth, D., Daly, A., Haber, P., Day, C. (2010), Patatin-like phospholipase domain containing 3: a case in point linking genetic susceptibility for alcoholic and nonalcoholic liver disease. Hepatology. 51(4), 1463-1465. [Abstract]
• Grebely, J., Petoumenos, K., Matthews, G., Haber, P., Marks, P., Lloyd, A., Kaldor, J., Dore, G., Hellard, M. (2010), Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study. Drug and alcohol dependence. 107(2-3), 244-9. [Abstract]
• Ramasamy, P., Lintzeris, N., Sutton, Y., Taylor, H., Day, C., Haber, P. (2010), The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic. Addiction. 105(2), 329-334. [Abstract]
• Dolan, K., Teutsch, S., Scheuer, N., Levy, M., Rawlinson, W., Kaldor, J., Lloyd, A., Haber, P. (2010), Incidence and risk for acute hepatitis C infection during imprisonment in Australia. European Journal of Epidemiology. 25(2), 143-148. [Abstract]
• Morley, K., Teesson, M., Sannibale, C., Baillie, A., Haber, P. (2010), Clinical Predictors of Outcome from an Australian Pharmacological Relapse Prevention Trial. Alcohol and alcoholism (Oxford, Oxfordshire). 45, 520-6. [Abstract]
• Seth, D., D'Souza El-Guindy, N., Apte, M., Mari, M., Dooley, S., Neuman, M., Haber, P., Kundu, G., Darwanto, A., de Villiers, W., Vonlaufen, A., Xu, Z., Phillips, P., Yang, S., Goldstein, D., Pirola, R., Wilson, J., Moles, A., Fernández, A., Colell, A., García-Ruiz, C., Fernández-Checa, J., Meyer, C., Meindl-Beinker, N. (2010), Alcohol, Signaling, and ECM Turnover. Alcoholism, clinical and experimental research. 34(1), 4-18. [Abstract]
• Teutsch, S., Luciani, F., Scheuer, N., McCredie, L., Hosseiny, P., Rawlinson, W., Kaldor, J., Dore, G., Dolan, K., Ffrench, R., Lloyd, A., Haber, P., Levy, M. (2010), Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort. BMC Public Health. 10, 633. [Abstract]
• Dore, G., Hellard, M., Matthews, G., Grebely, J., Haber, P., Petoumenos, K., Yeung, B., Marks, P., van Beek, I., McCaughan, G., White, P., French, R., Rawlinson, W., Lloyd, A., Kaldor, J. (2010), Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection. Gastroenterology. 138(1), 123-35.e1-2. [Abstract]

2009

• Haber, P., Demirkol, A., Lange, K., Murnion, B. (2009), Management of injecting drug users admitted to hospital. Lancet. 374(9697), 1284-1293. [Abstract]
• Leong, M., Murnion, B., Haber, P. (2009), Examination of Opioid Prescribing in Australia from 1992-2007. Internal medicine journal. 39(10), 676-81. [Abstract]
• Matthews, G., Hellard, M., Haber, P., Yeung, B., Marks, P., Baker, D., McCaughan, G., Sasadeusz, J., White, P., Rawlinson, W., Lloyd, A., Kaldor, J., Dore, G. (2009), Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C. Clinical Infectious Diseases. 48(5), 650-658. [Abstract]
• Day, C., Haber, P. (2009), Managing drug dependence in people with hepatitis C. In: Hepatitis C: An Expanding Perspective. (pp.288-307).Australia: IP Communications.
• Morley, K., Haber, P., Lintzeris, N. (2009), Pharmacotherapies for alcohol dependence. In: Guidelines for the Treatment of Alcohol Problems. (pp.93-106).Australia: Commonwealth of Australia.
• Morley, K., Teesson, M., Sannibale, C., Haber, P. (2009), Sample bias from different recruitment strategies in a randomised controlled trial for alcohol dependence. Drug and Alcohol Review. 28(3), 222-229.
• Addolorato, G., Russell, M., Albano, E., Haber, P., Wands, J., Leggio, L. (2009), Understanding and Treating Patients With Alcoholic Cirrhosis: An Update. Alcoholism-Clinical and Experimental Research. 33(7), 1136-1144. [Abstract]
• Haber, P., Lintzeris, N., Proude, E., Lopatko, O. (2009), Guidelines for the Treatment of Alcohol Problems. Australia: Commonwealth of Australia.
• Haber, P., Neasham, K. (2009), Alcohol and Drug Abuse. In: Palliative Medicine. (pp.451-458).United States: Saunders.
• Colagiuri, B., Morley, K., Boakes, R., Haber, P. (2009), Expectancy in double-blind placebo-controlled trials: an example from alcohol dependence. Psychotherapy and Psychosomatics. 78(3), 167-171. [Abstract]

2008

• Gong, M., Castillo, L., Redman, R., Garige, M., Hirsch, K., Azuine, M., Amdur, R., Seth, D., Haber, P., Lakshman, M. (2008), Down-regulation of liver Galbeta1, 4GlcNAc alpha2, 6-sialyltransferase gene by ethanol significantly correlates with alcoholic steatosis in humans. Metabolism: Clinical and Experimental. 57(12), 1663-1668. [Abstract]
• Lane, J., Proude, E., Conigrave, K., de Boer, J., Haber, P. (2008), Nurse-provided screening and brief intervention for risky alcohol consumption by sexual health clinic patients. Sexually transmitted infections. 84(7), 524-7. [Abstract]
• Dore, G., Haber, P. (2008), Tell me it ain't so: Patient-to-patient transmission of hepatitis C in an endoscopy clinic. Hepatology (Baltimore, Md.). 48(4), 1333-5. [Abstract]
• Wurst, F., Haber, P., Wiesbeck, G., Watson, B., Wallace, C., Whitfield, J., Halter, C., Weinmann, W., Conigrave, K. (2008), Assessment of alcohol consumption among hepatitis C-positive people receiving opioid maintenance treatment using direct ethanol metabolites and self-report: a pilot study. Addiction biology. 13(0), 416-22. [Abstract]
• Neuman, M., Sha, K., Esguerra, R., Zakhari, S., Winkler, R., Hilzenrat, N., Wyse, J., Cooper, C., Seth, D., Gorrell, M., Haber, P., McCaughan, G., Leo, M., Lieber, C., Voiculescu, M., Buzatu, E., Ionescu, C., Dudas, J., Saile, B., Ramadori, G. (2008), Inflammation and repair in viral hepatitis C. Digestive Diseases and Sciences. 53(6), 1468-1487. [Abstract]
• Richardson, K., Baillie, A., Reid, S., Morley, K., Teesson, M., Sannibale, C., Weltman, M., Haber, P. (2008), Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?. Addiction. 103(6), 953-959. [Abstract]
• Lintzeris, N., Lee, S., Scopelliti, L., Mabbutt, J., Haber, P. (2008), Unplanned admissions to two Sydney public hospitals after naltrexone implants. The Medical Journal of Australia. 188(8), 441-444. [Abstract]
• Seth, D., Hogg, P., Gorrell, M., McCaughan, G., Haber, P. (2008), Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease. Journal of hepatology. 48(4), 614-627. [Abstract]
• Thomson, C., Morley, K., Teesson, M., Sannibale, C., Haber, P. (2008), Issues with recruitment to randomised controlled trials in the drug and alcohol field: a literature review and Australian case study. Drug and alcohol review. 27(2), 115-122. [Abstract]
• Proude, E., Conigrave, K., Britton, A., Haber, P. (2008), Improving alcohol and tobacco history taking by junior medical officers. Alcohol and alcoholism. 43(3), 320-325. [Abstract]
• McCaughan, G., Shackel, N., Williams, R., Seth, D., Haber, P., Gorrell, M. (2008), Genomics, gene arrays and proteomics in the study of liver disease. In: The Textbook of Hepatology: From Basic Science to Clinical Practice. (pp.398-420).United States: Blackwell Publishing Ltd.
• Williams, G., Daly, M., Proude, E., Kermode, S., Davis, M., Barling, J., Haber, P. (2008), The influence of alcohol and tobacco use in orthopaedic inpatients on complications of surgery. Drug and Alcohol Review. 27(1), 55-64. [Abstract]

2007

• Haber, P., Young, M., Dorrington, L., Jones, A., Kaldor, J., De Kanzow, S., Rawlinson, W. (2007), Transmission of hepatitis C virus by needle-stick injury in community settings. Journal of gastroenterology and hepatology. 22(11), 1882-1885. [Abstract]
• Haber, P., McCaughan, G. (2007), "I'll never touch it again, doctor!" - harmful drinking after liver transplantation. Hepatology (Baltimore, Md.). 46(4), 1302-4. [Abstract]
• Watson, B., Conigrave, K., Wallace, C., Whitfield, J., Wurst, F., Haber, P. (2007), Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment. Drug and alcohol review. 26(3), 231-239. [Abstract]
• Shourie, S., Conigrave, K., Proude, E., Haber, P. (2007), Detection of and intervention for excessive alcohol and tobacco use among adult hospital in-patients. Drug and alcohol review. 26(2), 127-33. [Abstract]
• Shourie, S., Conigrave, K., Proude, E., Ward, J., Wutzke, S., Haber, P. (2007), Pre-operative screening for excessive alcohol consumption among patients scheduled for elective surgery. Drug and alcohol review. 26(2), 119-125. [Abstract]
• DAngelo, C., Addolorato, G., Haber, P., Gasbarrini, G., Zambon, A., Caputo, F., Abenavoli, L., Mirijello, A., Vonghia, L., Cardone, S., Leggio, L., Ferrulli, A. (2007), Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. LANCET. 370(9603), 1915-1922. [Abstract]
• McCaughan, G., Shackel, N., Williams, R., Seth, D., Haber, P., Gorrell, M. (2007), Genomics,gene arrays and proteomics in the study of liver disease. In: The Textbook of Hepatology: From Basic Science to Clinical Practice. (pp.398-420).United States: Blackwell Publishing Ltd.
• van Beek, I., Lloyd, A., Kaldor, J., Rowlinson, W., Ffrench, R., Pan, Y., McCaughan, G., Petoumenos, K., Yeung, B., Shaw, D., Haber, P., Matthews, G., Dore, G., Hellard, M. (2007), Treatment of recently acquired hepatitis C infection in injecting drug users: Preliminary results from the australian trial in acute hepatitis C (ATAHC). HEPATOLOGY. 46, 358A-358A. [Abstract]

2006

• Morley, K., Teesson, M., Reid, S., Sannibale, C., Thomson, C., Phung, N., Weltman, M., Bell, J., Richardson, K., Haber, P. (2006), Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial. Addiction (Abingdon, England). 101(10), 1451-62. [Abstract]
• Richardson, K., Reid, S., Morley, K., Teesson, M., Sannibale, C., Weltman, M., Baillee, A., Haber, P. (2006), The effects of alcohol and naltrexone on craving and alcohol consumption. Alcoholism-Clinical and Experimental Research. 30(9), 169A-169A. [Abstract]
• Seth, D., Hogg, P., D Gorrell, M., McCaughan, G., Haber, P. (2006), Identification of novel therapeutic targets for alcoholic liver disease. Alcoholism-Clinical and Experimental Research. 30(9), 60A-60A. [Abstract]
• Teesson, M., Morley, K., Reid, S., Sannibale, C., Thomson, C., Richardson, K., Haber, P. (2006), The influence of depression on pharmacotherapy for alcohol dependence. Alcoholism-Clinical and Experimental Research. 30(9), 68A-68A. [Abstract]
• Seth, D., Beard, M., Gorrell, M., McCaughan, G., Haber, P. (2006), Osteopontin: An early marker for alcoholic liver injury?. Alcoholism-Clinical and Experimental Research. 30(9), 89A-89A. [Abstract]
• Seth, D., Gorrell, M., Cordoba, S., McCaughan, G., Haber, P. (2006), Intrahepatic gene expression in human alcoholic hepatitis. Journal of hepatology. 45(2), 306-20. [Abstract]
• Haber, P. (2006), Commentary: Challenge for doctors and policy makers. British Medical Journal. 332(7536), 277-278. [Abstract]
• Proude, E., Conigrave, K., Haber, P. (2006), Effectiveness of skills-based training using the Drink-less package to increase family practitioner confidence in intervening for alcohol use disorders. BMC medical education [electronic resource]. 6, 8. [Abstract]
• Shourie, S., Conigrave, K., Proude, E., Ward, J., Wutzke, S., Haber, P. (2006), The Effectiveness of a Tailored Intervention for Excessive Alcohol Consumption Prior to Elective Surgery. Alcohol and alcoholism (Oxford, Oxfordshire). 41, 643-9. [Abstract]
• Shackel, N., Seth, D., Haber, P., Gorrell, M., McCaughan, G. (2006), The hepatic transcriptome in human liver disease. Comparative hepatology [electronic resource]. 5, 6. [Abstract]
• Kelly, M., Chick, J., Gribble, R., Gleeson, M., Holton, M., Winstanley, J., McCaughan, G., Haber, P. (2006), Predictors of relapse to harmful alcohol after orthotopic liver transplantation. Alcohol and Alcoholism. 41(3), 278-283. [Abstract]